WO2026063904 - SUMMARY A NON-INVASIVE SCREENING METHOD FOR NON-SMALL CELL LUNG CANCER (NSCLC)
National phase entry is expected:
Publication Number
WO/2026/063904
Publication Date
26.03.2026
International Application No.
PCT/TR2025/051141
International Filing Date
16.09.2025
Title **
[English]
SUMMARY A NON-INVASIVE SCREENING METHOD FOR NON-SMALL CELL LUNG CANCER (NSCLC)
[French]
RÉCAPITULATIF D'UN PROCÉDÉ DE CRIBLAGE NON INVASIF POUR CANCER DU POUMON NON À PETITES CELLULES (CPNPC)
Applicants **
SANKO ÜNİVERSİTESİ
Inventors
DEMİRAĞ, Aliye Demet
ŞAHİN, Fikrettin
YILDIRIM, Mustafa
ELBEYLİ, Levent
Priority Data
2024/012421
18.09.2024
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2216 | |
| EPO | Filing, Examination, Granting | 11215 | |
| Japan | Filing, Examination, Granting | 2279 | |
| South Korea | Filing, Examination, Granting | 2403 | |
| USA | Filing, Examination, Granting | 13740 |
Total:
31,853
Contact Us
Abstract[English]
The invention is a non-invasive screening method for non-small cell lung cancer (NSCLC), developed for use in the healthcare and medical device manufacturing sectors. Its features include: preparing serum samples by taking blood from patients for use in spectroscopic analysis; Performing molecular structure analyses using Raman spectroscopy; measuring molecular bond vibrations using FT-IR spectroscopy; processing spectral data, evaluating results, and establishing a decision mechanism for NSCLC detection by performing PCA, LDA, and ROC analyses using data analysis software.[French]
L'invention concerne un procédé de criblage non invasif pour le cancer du poumon non à petites cellules (CPNPC), développé pour être utilisé dans les secteurs industriels des dispositifs de soins de santé et médicaux. Ses caractéristiques comprennent : la préparation d'échantillons de sérum par prélèvement de sang de patients destinés à être utilisés dans une analyse spectroscopique ; la réalisation d'analyses de structure moléculaire à l'aide d'une spectroscopie Raman ; la mesure de vibrations de liaison moléculaire à l'aide d'une spectroscopie IRTF ; le traitement de données spectrales, l'évaluation de résultats, et l'établissement d'un mécanisme de décision pour la détection du CPNPC par réalisation d'analyses PCA, LDA et ROC à l'aide d'un logiciel d'analyse de données.